OPEN: Blood Cancer United 2026-2027 SCOR research grant competition; letters of intent accepted through December 8, 2026 at 3 p.m. EST. Only invited applicants may submit full applications by March 30, 2027 at 3 p.m. EDT.
International — Blood Cancer United 2026–2027 Specialized Center of Research (SCOR) Grants (Up to $5,000,000; December 8 LOI)
Blood Cancer United 2026–2027 SCOR research grants offer up to $5,000,000 over five years per qualifying international nonprofit research center. Competitive LOIs due December 8, 2026 at 3 p.m. EST.
FundingUp to $5,000,000 USD for ONE qualifying SCOR award over 5 years, capped at $1,000,000 annually inclusive of up to $150,000 annual indirect costs (15%). Two separate SCOR grants anticipated across the overall 2026-2027 cycle; one award ceiling is not the overall program pool.
DeadlineOPEN: Letter of intent due December 8, 2026 at 3:00 p.m. Eastern Standard Time (EST). By invitation only, full application due March 30, 2027 at 3:00 p.m. Eastern Daylight Time (EDT).
Last verified2026-11-06
Required next actionCheck eligibility for a nonprofit academic research institution and eligible doctoral-level investigators. Assemble an integrated three-to-five-Project SCOR with one Administrative Core; register for the Blood Cancer United Research Portal at https://bloodcancerunited.org/research/grants/specialized-center-research-program-scor. Submit the online LOI and single PDF with NIH Biosketches and Other Support for the required leaders before December 8, 2026 at 3 p.m. EST. Invited applicants must then follow the current full Guidelines, template, budget and IRB/IACUC instructions for the March 30, 2027 3 p.m. EDT deadline.
Broad Eligibility
International eligible academic/nonprofit research institutions and interdisciplinary blood cancer research teams. SCOR Director and key personnel must hold PhD, MD, DVM or equivalent and maintain nonprofit institutional affiliation. Each proposal requires 3-5 Projects, one Administrative Core and up to 3 Scientific Cores, integrated with bench-to-bedside clinical translation. Two program priorities include myelodysplastic syndromes and other stated hematologic malignancies.
Atlas Analysis
Verified November 6, 2026 using Blood Cancer United official 2026-2027 SCOR program page and detailed FY27 FAQ derived from funder guidelines. Genuine competitive research financial-assistance award, not procurement. One SCOR applicant may request no more than $5,000,000 over five years, $1,000,000/year inclusive of annual indirect-cost ceiling $150,000 (15% of annual cost). Funder anticipates two separate awards, not a $5 million total program pool. LOI Dec 8 2026 3 p.m. EST; invited full proposal Mar 30 2027 3 p.m. EDT. Worldwide academic/nonprofit research institutions; SCOR leader doctoral/medical degree and continuing nonprofit affiliation; 3-5 research Projects and required Administrative Core. Personnel, services, supplies, research equipment at or below $20,000/item and patient costs allowed when justified; general operating costs, memberships, tuition, books, gifts, lobbying excluded. No universal cost-share stated. Registration and online LOI via research portal; NIH Biosketch and Other Support PDF required; regulatory/IRB/IACUC documents before award and disclosures. Downloadable guideline PDF could not be independently fetched; public official FAQ contains funder-authored application details and states template controls in conflicts. Applicants must review original template and guidelines.
Grant opportunity
The Blood Cancer United Specialized Center of Research (SCOR) 2026–2027 competition offers competitive grants for integrated, multi-institutional or single-institution teams conducting basic, translational and clinical research to improve diagnosis, prevention and treatment of blood cancers. The funder anticipates two SCOR awards for this cycle: one focused on myelodysplastic syndromes in partnership with the Edward P. Evans Foundation, and one prioritizing T-cell lymphoma, myeloproliferative neoplasms, multiple myeloma or pediatric leukemia. Other highly compelling blood cancer proposals may be considered.
Individual award funding and deadline
A qualifying SCOR consortium may receive up to $5,000,000 over five years, with no more than $1,000,000 per award year. This is the ceiling for one SCOR award, not the total pool for the two expected awards. Annual indirect costs cannot exceed $150,000 (15% of total annual costs). The initial letter of intent is due December 8, 2026 at 3:00 p.m. Eastern Standard Time. Only invited applicants may submit full applications, due March 30, 2027 at 3:00 p.m. Eastern Daylight Time.
Eligibility and team requirements
Eligible research teams are welcomed internationally from appropriate academic and nonprofit research institutions. The SCOR Director and key scientific personnel must hold a PhD, MD, DVM or equivalent degree and remain affiliated with a nonprofit institution throughout funding. Every center must include three to five synergistic scientific Projects, one Administrative Core, and up to three optional Scientific Cores. The SCOR Director must lead one Project, and each Project Leader may lead only one Project within that SCOR. Investigators must demonstrate multidisciplinary integration and a credible route from experimental discoveries to clinical application.
Allowable costs and restrictions
Justified direct research expenses may include personnel, materials, scientific services, research equipment and patient-associated costs. Equipment is limited to $20,000 per item. Membership dues, tuition, books, journals, general operating costs, endowment or gift payments, lobbying and political activities are ineligible. Research involving human participants or animals must satisfy applicable IRB or IACUC approval requirements before award. Applicants must disclose current and pending research support, including potentially overlapping projects. The program does not announce a standard required applicant cash-match percentage.
How to apply
Review the official 2026–2027 SCOR funding page, FAQ, guidelines, application templates and research-portal links. Register in the Blood Cancer United Research Portal and complete the LOI web form. Upload one consolidated PDF containing current NIH Biosketches and NIH Other Support forms for the SCOR Director and all Project and Core Leaders. LOI scientific abstracts must meet the funder’s character and formatting restrictions; no figures or references are permitted at the LOI stage. Invited teams must provide the required full application components and budgets in the prescribed template, meeting all formatting and regulatory requirements. The funder’s official application template controls if it differs from general guidance. Do not submit after the stated deadline.
Official-source review: November 6, 2026. Applicants must consult the controlling current downloadable SCOR Guidelines and application template for every submission detail.
Source verificationReferenced source · bloodcancerunited.orgAtlas last verified this record 2026-11-06. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
